The DOI matches its Crossref record; 245 of the 245 references it cites were found in a registry or an index.
Current Enlightenment About Etiology and Pharmacological Treatment of Autism Spectrum Disorder
Open accessAbstract
Autistic Spectrum Disorder (ASD) is a complex neurodevelopmental brain disorder characterized by two core behavioral symptoms, namely impairments in social communication and restricted/repetitive behavior. The molecular mechanisms underlying ASD are not well understood. Recent genetic as well as non-genetic animal models contributed significantly in understanding the pathophysiology of ASD, as they establish autism-like behavior in mice and rats. Among the genetic causes, several chromosomal mutations including duplications or deletions could be possible causative factors of ASD. In addition, the biochemical basis suggests that several brain neurotransmitters, e.g., dopamine (DA), serotonin (5-HT), gamma-amino butyric acid (GABA), acetylcholine (ACh), glutamate (Glu) and histamine (HA) participate in the onset and progression of ASD. Despite of convincible understanding, risperidone and aripiprazole are the only two drugs available clinically for improving behavioral symptoms of ASD following approval by Food and Drug Administration (FDA). Till date, up to our knowledge there is no other drug approved for clinical usage specifically for ASD symptoms. However, many novel drug candidates and classes of compounds are underway for ASD at different phases of preclinical and clinical drug development. In this review, the diversity of numerous aetiological factors and the alterations in variety of neurotransmitter generation, release and function linked to ASD are discussed with focus on drugs currently used to manage neuropsychiatric symptoms related to ASD. The review also highlights the clinical development of drugs with emphasis on their pharmacological targets aiming at improving core symptoms in ASD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Shrestha, S., & Offer, S. M. (2016) · Medical Epigenetics · doi:10.1159/000444713 · Cited by 8,914
Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2
Amir, R. E., Van den Veyver, I. B., Wan, M., Tran, C. Q., Francke, U., & Zoghbi, H. Y. (1999) · Nature Genetics · doi:10.1038/13810 · Cited by 4,990
Rate of de novo mutations and the importance of father’s age to disease risk
Kong, A., Frigge, M. L., Masson, G., Besenbacher, S., Sulem, P., Magnusson, G., Gudjonsson, S. A., Sigurdsson, A., Jonasdottir, A., Jonasdottir, A., et al. (2012) · Nature · doi:10.1038/nature11396 · Cited by 2,134 · cited 2×
“Consequently, the timing of immune insults during developmental phase may be one source of the heterogeneity in the phenotypic features observed in ASD (Kong et al., 2012).”
BackgroundAnimal models of neuropsychiatric disorders
Nestler, E. J., & Hyman, S. E. (2010) · Nature Neuroscience · doi:10.1038/nn.2647 · Cited by 2,023
Genetic Heritability and Shared Environmental Factors Among Twin Pairs With Autism
Hallmayer, J. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.76 · Cited by 1,970 · cited 1×
“In a previous clinical study involving a twin, it was appraised that the risk of developing ASD was 35–40% due to genetic variability, and the remaining 60% was contributed to by prenatal, perinatal, and postnatal environmental factors (Hallmayer et al., 2011).”
BackgroundBurnside, R. D. (2015) · Cytogenetic and Genome Research · doi:10.1159/000438708 · Cited by 1,946
Transcriptomic Analysis of Autistic Brain Reveals Convergent Molecular Pathology
Voineagu, I., Wang, X., Johnston, P., Lowe, J. K., Tian, Y., Horvath, S., Mill, J., Cantor, R. M., Blencowe, B. J., & Geschwind, D. H. (2011) · Nature · doi:10.1038/nature10110 · Cited by 1,874 · cited 1×
“Moreover, genetic studies revealed that alteration in the developmental pathways of neuronal and axonal structures that are strongly involved in synaptogenesis emerge from single gene mutations (Geschwind, 2011; Voineagu et al., 2011; Chang et al., 2015).”
BackgroundRisperidone in Children with Autism and Serious Behavioral Problems
McCracken, J. T., McGough, J., Shah, B., Cronin, P., Hong, D., Aman, M. G., Arnold, L. E., Lindsay, R., Nash, P., Hollway, J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013171 · Cited by 1,574 · cited 5×
“The antipsychotic medication with risperidone is mainly approached in ASD patients with SCH, bipolar disorder, and/or irritability symptoms, as this drug has revealed to be better than placebo in treating irritability, repetitive behavior, aggression, anxiety, depression and nervousness (McDougle et al., 1998b; McCrac…”
BackgroundInfluentialRecent Segmental Duplications in the Human Genome
Bailey, J. A., Gu, Z., Clark, R. A., Reinert, K., Samonte, R. V., Schwartz, S., Adams, M. D., Myers, E. W., Li, P. W., & Eichler, E. E. (2002) · Science · doi:10.1126/science.1072047 · Cited by 1,352
UBE3A/E6-AP mutations cause Angelman syndrome
Kishino, T., Lalande, M., & Wagstaff, J. (1997) · Nature Genetics · doi:10.1038/ng0197-70 · Cited by 1,298
Histamine in the Nervous System
Haas, H. L., Sergeeva, O. A., & Selbach, O. (2008) · Physiological Reviews · doi:10.1152/physrev.00043.2007 · Cited by 1,228
Muhle, R., Trentacoste, S. V., & Rapin, I. (2004) · Pediatrics · doi:10.1542/peds.113.5.e472 · Cited by 1,207
Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes
Chao, H.-T., Chen, H., Samaco, R. C., Xue, M., Chahrour, M., Yoo, J., Neul, J. L., Gong, S., Lu, H.-C., Heintz, N., et al. (2010) · Nature · doi:10.1038/nature09582 · Cited by 1,168
Peñagarikano, O., Abrahams, B. S., Herman, E. I., Winden, K. D., Gdalyahu, A., Dong, H., Sonnenblick, L. I., Gruver, R., Almajano, J., Bragin, A., et al. (2011) · Cell · doi:10.1016/j.cell.2011.08.040 · Cited by 1,075 · cited 1×
“Moreover, deficiency in CNTNAP2 results in reduction in GAD1, parvalbumin and inhibitory interneurons along with impairments in inhibitory signaling (Peñagarikano et al., 2011; Soghomonian et al., 2017).”
BackgroundThe Changing Epidemiology of Autism Spectrum Disorders
Lyall, K., Croen, L., Daniels, J., Fallin, M. D., Ladd-Acosta, C., Lee, B. K., Park, B. Y., Snyder, N. W., Schendel, D., Volk, H., et al. (2017) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-031816-044318 · Cited by 1,011
Maternal Infection Requiring Hospitalization During Pregnancy and Autism Spectrum Disorders
Atladóttir, H. Ó., Thorsen, P., Østergaard, L., Schendel, D. E., Lemcke, S., Abdallah, M., & Parner, E. T. (2010) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-010-1006-y · Cited by 916
De novo truncating mutations in E6-AP ubiquitin-protein ligase gene (UBE3A) in Angelman syndrome
Matsuura, T., Sutcliffe, J. S., Fang, P., Galjaard, R.-J., Jiang, Y.-H., Benton, C. S., Rommens, J. M., & Beaudet, A. L. (1997) · Nature Genetics · doi:10.1038/ng0197-74 · Cited by 856
(1959) · PubMed · Cited by 820
Autism‐like behavioral phenotypes in BTBR T+tf/J mice
McFarlane, H. G., Kusek, G. K., Yang, M., Phoenix, J. L., Bolivar, V. J., & Crawley, J. N. (2008) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2007.00330.x · Cited by 812 · cited 1×
“…(BALB), BTBR T+Itpr3tf/J (BTBR), C58/J (C58), and 129S1/SvImJ mice showed lack of sociability, as compared to inbred mouse strains with high sociability, such as C57BL/6J (B6) and FVB/NJ mice (Brodkin, 2007; Moy et al., 2007, 2008; McFarlane et al., 2008; Kazdoba et al., 2016; Hu et al., 2017).”
BackgroundMouse behavioral tasks relevant to autism: Phenotypes of 10 inbred strains
MOY, S., NADLER, J., YOUNG, N., PEREZ, A., HOLLOWAY, L., BARBARO, R., BARBARO, J., WILSON, L., THREADGILL, D., & LAUDER, J. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.07.030 · Cited by 776
Genetics of autism spectrum disorders
Geschwind, D. H. (2011) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2011.07.003 · Cited by 696
Perinatal and Neonatal Risk Factors for Autism: A Comprehensive Meta-analysis
Gardener, H., Spiegelman, D., & Buka, S. L. (2011) · Pediatrics · doi:10.1542/peds.2010-1036 · Cited by 665 · cited 2×
“, 2014), birth and neonatal complications (Gardener et al., 2011; Guinchat et al., 2012), viral infection, autoimmune diseases, and exposure to teratogens and maternal anticonvulsants such as valproic acid (VPA) (Kern and Jones, 2006; Kolevzon et al.”
BackgroundCopy-number variations associated with neuropsychiatric conditions
Cook Jr, E. H., & Scherer, S. W. (2008) · Nature · doi:10.1038/nature07458 · Cited by 659
Aripiprazole in the Treatment of Irritability in Children and Adolescents With Autistic Disorder
Owen, R., Sikich, L., Marcus, R. N., Corey-Lisle, P., Manos, G., McQuade, R. D., Carson, W. H., & Findling, R. L. (2009) · Pediatrics · doi:10.1542/peds.2008-3782 · Cited by 613 · cited 3×
“However, it displays an antagonist profile at 5-HT2A and 5-HT7 receptors and acts as a partial agonist at the 5-HT2C receptor, both with high affinity (Marcus et al., 2009; Owen et al., 2009; Hirsch and Pringsheim, 2016).”
BackgroundThe valproic acid-induced rodent model of autism
Nicolini, C., & Fahnestock, M. (2018) · Experimental Neurology · doi:10.1016/j.expneurol.2017.04.017 · Cited by 592
Neuropathology of Infantile Autism
Kemper, T. L., & Bauman, M. (1998) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199807000-00001 · Cited by 585
Marcus, R. N., Owen, R., Kamen, L., Manos, G., McQuade, R. D., Carson, W. H., & Aman, M. G. (2009) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e3181b76658 · Cited by 566
A clinical study of 57 children with fetal anticonvulsant syndromes
Moore, S. J., Turnpenny, P., Quinn, A., Glover, S., Lloyd, D. J., Montgomery, T., & Dean, J. C. S. (2000) · Journal of Medical Genetics · doi:10.1136/jmg.37.7.489 · Cited by 562
A Double-blind, Placebo-Controlled Study of Fluvoxamine in Adults With Autistic Disorder
McDougle, C. J. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830110037005 · Cited by 556
Lord, C., Cook, E. H., Leventhal, B. L., & Amaral, D. G. (2000) · Neuron · doi:10.1016/s0896-6273(00)00115-x · Cited by 555
Perinatal Factors and the Development of Autism: A Population Study
Glasson, E. J., Bower, C., Petterson, B., de Klerk, N., Chaney, G., & Hallmayer, J. F. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.6.618 · Cited by 519
Postmortem brain abnormalities of the glutamate neurotransmitter system in autism
Purcell, A. E., Jeon, O. H., Zimmerman, A. W., Blue, M. E., & Pevsner, J. (2001) · Neurology · doi:10.1212/wnl.57.9.1618 · Cited by 518
Prenatal and Perinatal Risk Factors for Autism: A Review and Integration of Findings
Kolevzon, A., Gross, R., & Reichenberg, A. (2007) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.161.4.326 · Cited by 510
Fatemi, S. H., Halt, A. R., Stary, J. M., Kanodia, R., Schulz, S. C., & Realmuto, G. R. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01430-0 · Cited by 500
Autism genetics: opportunities and challenges for clinical translation
Vorstman, J. A. S., Parr, J. R., Moreno-De-Luca, D., Anney, R. J. L., Nurnberger Jr, J. I., & Hallmayer, J. F. (2017) · Nature Reviews Genetics · doi:10.1038/nrg.2017.4 · Cited by 463
The 22q13.3 Deletion Syndrome (Phelan-McDermid Syndrome)
Phelan, K., & McDermid, H. E. (2011) · Molecular Syndromology · doi:10.1159/000334260 · Cited by 460
Post-transcriptional Regulation of α-Synuclein Expression by mir-7 and mir-153
Doxakis, E. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.086827 · Cited by 454
AUTISM IN THALIDOMIDE EMBRYOPATHY: A POPULATION STUDY
Strömland, K., Nordin, V., Miller, M., Akerström, B., & Gillberg, C. (1994) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.1994.tb11856.x · Cited by 453
Subtle chromosomal rearrangements in children with unexplained mental retardation
Knight, S. J., Regan, R., Nicod, A., Horsley, S. W., Kearney, L., Homfray, T., Winter, R. M., Bolton, P., & Flint, J. (1999) · The Lancet · doi:10.1016/s0140-6736(99)03070-6 · Cited by 453
GABA system dysfunction in autism and related disorders: From synapse to symptoms
Coghlan, S., Horder, J., Inkster, B., Mendez, M. A., Murphy, D. G., & Nutt, D. J. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.07.005 · Cited by 446
Leblond, C. S., Heinrich, J., Delorme, R., Proepper, C., Betancur, C., Huguet, G., Konyukh, M., Chaste, P., Ey, E., Rastam, M., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002521 · Cited by 429
McDougle, C. J., Holmes, J. P., Carlson, D. C., Pelton, G. H., Cohen, D. J., & Price, L. H. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.7.633 · Cited by 427
Ethotransmission: communication of emotional states through ultrasonic vocalization in rats.
Brudzynski, S. M. (2013) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2013.01.014 · Cited by 416 · cited 2×
“Notably, rat has become the most extensively used animals in the context of SCH and ASD neuroscience (Brudzynski, 2013).”
BackgroundRavnan, J. B., Tepperberg, J. H., Papenhausen, P., Lamb, A. N., Hedrick, J., Eash, D., Ledbetter, D. H., & Martin, C. L. (2006) · Journal of Medical Genetics · doi:10.1136/jmg.2005.036350 · Cited by 412
Hollander, E., Phillips, A., Chaplin, W., Zagursky, K., Novotny, S., Wasserman, S., & Iyengar, R. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300627 · Cited by 408
Angelman syndrome — insights into a rare neurogenetic disorder
Buiting, K., Williams, C., & Horsthemke, B. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.133 · Cited by 397
Gordon, C. T. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820180039004 · Cited by 390
Cholinergic Activity in Autism: Abnormalities in the Cerebral Cortex and Basal Forebrain
Perry, E. K., Lee, M. L. W., Martin-Ruiz, C. M., Court, J. A., Volsen, S. G., Merrit, J., Folly, E., Iversen, P. E., Bauman, M. L., Perry, R. H., et al. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.7.1058 · Cited by 387
Volkmar, F., Cook, E. H., Pomeroy, J., Realmuto, G., & Tanguay, P. (1999) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/s0890-8567(99)80003-3 · Cited by 382
Autism Spectrum Phenotype in Males and Females with Fragile X Full Mutation and Premutation
Clifford, S., Dissanayake, C., Bui, Q. M., Huggins, R., Taylor, A. K., & Loesch, D. Z. (2007) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-006-0205-z · Cited by 377
Association Between Thimerosal-Containing Vaccine and Autism
Hviid, A. (2003) · JAMA · doi:10.1001/jama.290.13.1763 · Cited by 371
Linkage-disequilibrium mapping of autistic disorder, with 15q11-13 markers
Cook, E. H., Courchesne, R. Y., Cox, N. J., Lord, C., Gonen, D., Guter, S. J., Lincoln, A., Nix, K., Haas, R., Leventhal, B. L., et al. (1998) · The American Journal of Human Genetics · doi:10.1086/301832 · Cited by 369 · cited 2×
“Previous reports suggested, also, several cases of ASD with cytogenetic abnormalities in the 15q11–13 region (Cook et al., 1998), and the frequency of cytogenetic abnormalities in this region was found to be around 0-3% in ASD, and in fact, the most frequent cytogenetic abnormality in this population (Lord et al.”
BackgroundGaray, P. A., Hsiao, E. Y., Patterson, P. H., & McAllister, A. K. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.07.008 · Cited by 366 · cited 2×
“Indeed, when animals were exposed to the maternal immune activation with polyinosine:cytosine (poly I:C) at embryonic day 9.5, the offspring displayed histological and behavioral abnormalities that resembled ASD (Shi et al., 2009; Hsiao et al., 2012; Garay et al., 2013).”
BackgroundInfluentialEpigenetic Modulation of Seizure-Induced Neurogenesis and Cognitive Decline
Jessberger, S., Nakashima, K., Clemenson, G. D., Mejia, E., Mathews, E., Ure, K., Ogawa, S., Sinton, C. M., Gage, F. H., & Hsieh, J. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.0110-07.2007 · Cited by 353
The comorbidity of autism with the genomic disorders of chromosome 15q11.2-q13
Hogart, A., Wu, D., LaSalle, J. M., & Schanen, N. C. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.08.011 · Cited by 351
Howes, O. D., Rogdaki, M., Findon, J. L., Wichers, R. H., Charman, T., King, B. H., Loth, E., McAlonan, G. M., McCracken, J. T., Parr, J. R., et al. (2018) · Journal of Psychopharmacology · doi:10.1177/0269881117741766 · Cited by 342
Kataoka, S., Takuma, K., Hara, Y., Maeda, Y., Ago, Y., & Matsuda, T. (2013) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711001714 · Cited by 341
Modeling an autism risk factor in mice leads to permanent immune dysregulation
Hsiao, E. Y., McBride, S. W., Chow, J., Mazmanian, S. K., & Patterson, P. H. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1202556109 · Cited by 340 · cited 2×
“Indeed, when animals were exposed to the maternal immune activation with polyinosine:cytosine (poly I:C) at embryonic day 9.5, the offspring displayed histological and behavioral abnormalities that resembled ASD (Shi et al., 2009; Hsiao et al., 2012; Garay et al., 2013).”
BackgroundInfluentialSchneider, T., Roman, A., Basta-Kaim, A., Kubera, M., Budziszewska, B., Schneider, K., & Przewłocki, R. (2008) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.02.011 · Cited by 337
Fetal Valproate Syndrome: Clinical and Neuro‐developmental Features in Two Sibling Pairs
Christianson, A. L., Chester, N., & Kromberg, J. G. R. (1994) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.1994.tb11858.x · Cited by 336
Veenstra-VanderWeele, J., Muller, C. L., Iwamoto, H., Sauer, J. E., Owens, W. A., Shah, C. R., Cohen, J., Mannangatti, P., Jessen, T., Thompson, B. J., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1112345109 · Cited by 333 · cited 1×
“…and in a previous study, higher clearance rates of hippocampal 5-HT were observed and hence hyperserotonemia, which led to a significant hypersensitivity of brain 5-HT(1A) as well as 5- HT(2A) receptors, social impairment and repetitive behavior (Veenstra-VanderWeele et al., 2012; Figure 1).”
BackgroundPrevalence of Autism Spectrum Disorder Among US Children and Adolescents, 2014-2016
Xu, G., Strathearn, L., Liu, B., & Bao, W. (2018) · JAMA · doi:10.1001/jama.2017.17812 · Cited by 333
Handen, B. L., Johnson, C. R., & Lubetsky, M. (2000) · Journal of Autism and Developmental Disorders · doi:10.1023/a:1005548619694 · Cited by 326
Genetic overlap between autism, schizophrenia and bipolar disorder
Carroll, L. S., & Owen, M. J. (2009) · Genome Medicine · doi:10.1186/gm102 · Cited by 326
Chisholm, K., Lin, A., Abu-Akel, A., & Wood, S. J. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.04.012 · Cited by 317
Bhattacharya, A., Kaphzan, H., Alvarez-Dieppa, A. C., Murphy, J. P., Pierre, P., & Klann, E. (2012) · Neuron · doi:10.1016/j.neuron.2012.07.022 · Cited by 316
Linkage and association of the glutamate receptor 6 gene with autism
Jamain, S., Betancur, C., Quach, H., Philippe, A., Fellous, M., Giros, B., Gillberg, C., Leboyer, M., Bourgeron, T., & Study, A. T. P. A. R. I. S. (. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4000979 · Cited by 313
Use of Complementary and Alternative Medicine among Children Diagnosed with Autism Spectrum Disorder
Hanson, E., Kalish, L. A., Bunce, E., Curtis, C., McDaniel, S., Ware, J., & Petry, J. (2007) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-006-0192-0 · Cited by 301
The histamine H3receptor: an attractive target for the treatment of cognitive disorders
Esbenshade, T. A., Browman, K. E., Bitner, R. S., Strakhova, M., Cowart, M. D., & Brioni, J. D. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.147 · Cited by 296
Pre‐, peri‐ and neonatal risk factors for autism
GUINCHAT, V., THORSEN, P., LAURENT, C., CANS, C., BODEAU, N., & COHEN, D. (2012) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.1111/j.1600-0412.2011.01325.x · Cited by 294
A Dopamine Hypothesis of Autism Spectrum Disorder
Pavăl, D. (2017) · Developmental Neuroscience · doi:10.1159/000478725 · Cited by 294
Ullmann, R., Turner, G., Kirchhoff, M., Chen, W., Tonge, B., Rosenberg, C., Field, M., Vianna-Morgante, A. M., Christie, L., Krepischi-Santos, A. C., et al. (2007) · Human Mutation · doi:10.1002/humu.20546 · Cited by 286
Activation of the maternal immune system alters cerebellar development in the offspring
Shi, L., Smith, S. E. P., Malkova, N., Tse, D., Su, Y., & Patterson, P. H. (2009) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2008.07.012 · Cited by 277
Methylmercury Exposure Biomarkers as Indicators of Neurotoxicity in Children Aged 7 Years
Grandjean, P., Budtz-Jorgensen, E., White, R. F., Jorgensen, P. J., Weihe, P., Debes, F., & Keding, N. (1999) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a010002 · Cited by 274
Christian, S. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.6.1025 · Cited by 270
Evidence of Toxicity, Oxidative Stress, and Neuronal Insult in Autism
Kern, J. K., & Jones, A. M. (2006) · Journal of Toxicology and Environmental Health, Part B · doi:10.1080/10937400600882079 · Cited by 265
Use of psychotropic drugs in patients with autism spectrum disorders: a systematic review
Jobski, K., Höfer, J., Hoffmann, F., & Bachmann, C. (2017) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12644 · Cited by 263
Autistic Disorder and Schizophrenia: Diagnostic Overlaps
Konstantareas, M. M., & Hewitt, T. (2001) · Journal of Autism and Developmental Disorders · doi:10.1023/a:1005605528309 · Cited by 255
The Emerging Picture of Autism Spectrum Disorder: Genetics and Pathology
Chen, J. A., Peñagarikano, O., Belgard, T. G., Swarup, V., & Geschwind, D. H. (2015) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012414-040405 · Cited by 254
Autistic disorder and viral infections
Libbey, J., Sweeten, T., McMahon, W., & Fujinami, R. (2005) · Journal of NeuroVirology · doi:10.1080/13550280590900553 · Cited by 252 · cited 1×
“Also and subsequent to viral infection, the immune response was found to produce various cytokines, such as interleukins (IL)-1,-2 and -6 which modulate the release of several monoamines such as 5-HT in the hippocampus and other brain regions (Libbey et al., 2005).”
BackgroundScott-Van Zeeland, A. A., Abrahams, B. S., Alvarez-Retuerto, A. I., Sonnenblick, L. I., Rudie, J. D., Ghahremani, D., Mumford, J. A., Poldrack, R. A., Dapretto, M., Geschwind, D. H., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001344 · Cited by 252 · cited 1×
“…focal epilepsy with deficits in regard to social interactions, restricted interest, sensory sensitivity, elevated anxiety, and seizures (Scott-Van Zeeland et al., 2010) (Cook and Scherer, 2008; LaSalle et al., 2015; Piochon et al., 2015) as behavioral features of the above described syndromes…”
BackgroundDisrupted Homer scaffolds mediate abnormal mGluR5 function in a mouse model of fragile X syndrome
Ronesi, J. A., Collins, K. A., Hays, S. A., Tsai, N.-P., Guo, W., Birnbaum, S. G., Hu, J.-H., Worley, P. F., Gibson, J. R., & Huber, K. M. (2012) · Nature Neuroscience · doi:10.1038/nn.3033 · Cited by 251
Linking etiologies in humans and animal models: Studies of autism
Rodier, P. M., Ingram, J. L., Tisdale, B., & Croog, V. J. (1997) · Reproductive Toxicology · doi:10.1016/s0890-6238(97)80001-u · Cited by 247
Neurochemical and Behavioral Effects of Ciproxifan, A Potent Histamine H3-Receptor Antagonist
Ligneau, X., Lin, J.-S., Vanni-Mercier, G., Jouvet, M., Muir, J. L., Ganellin, C. R., Stark, H., Elz, S., Schunack, W., & Schwartz, J.-C. (1998) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37840-1 · Cited by 242
James, S. J., Melnyk, S., Fuchs, G., Reid, T., Jernigan, S., Pavliv, O., Hubanks, A., & Gaylor, D. W. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.26615 · Cited by 241
Hogart, A., Nagarajan, R. P., Patzel, K. A., Yasui, D. H., & LaSalle, J. M. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm014 · Cited by 233
Spatial Working Memory Deficits in Autism
Steele, S. D., Minshew, N. J., Luna, B., & Sweeney, J. A. (2007) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-006-0202-2 · Cited by 232
Chromatin remodeling in neural development and plasticity
Hsieh, J., & Gage, F. H. (2005) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2005.09.002 · Cited by 228
Hollander, E., Chaplin, W., Soorya, L., Wasserman, S., Novotny, S., Rusoff, J., Feirsen, N., Pepa, L., & Anagnostou, E. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.202 · Cited by 224
Wong, H. H. L., & Smith, R. G. (2006) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-006-0131-0 · Cited by 224
Asztély, F., & Gustafsson, B. (1996) · Molecular Neurobiology · doi:10.1007/bf02740744 · Cited by 223
BALB/c mice: Low sociability and other phenotypes that may be relevant to autism
BRODKIN, E. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.06.025 · Cited by 223
Chez, M. G., Burton, Q., Dowling, T., Chang, M., Khanna, P., & Kramer, C. (2007) · Journal of Child Neurology · doi:10.1177/0883073807302611 · Cited by 221
Ragozzino, M. E., Pal, S. N., Unick, K., Stefani, M. R., & Gold, P. E. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-04-01595.1998 · Cited by 214
Hamilton, P. J., Campbell, N. G., Sharma, S., Erreger, K., Herborg Hansen, F., Saunders, C., Belovich, A. N., NIH ARRA Autism Sequencing Consortium, Daly, M. J., Gibbs, R. A., et al. (2013) · Molecular Psychiatry · doi:10.1038/mp.2013.102 · Cited by 212
(1992) · PubMed · Cited by 207
Preclinical research in Rett syndrome: setting the foundation for translational success
Katz, D. M., Berger-Sweeney, J. E., Eubanks, J. H., Justice, M. J., Neul, J. L., Pozzo-Miller, L., Blue, M. E., Christian, D., Crawley, J. N., Giustetto, M., et al. (2012) · Disease Models & Mechanisms · doi:10.1242/dmm.011007 · Cited by 206
Epigenetic control of neural stem cell fate
Hsieh, J., & Gage, F. H. (2004) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2004.07.006 · Cited by 205
Acetylcholine Elevation Relieves Cognitive Rigidity and Social Deficiency in a Mouse Model of Autism
Karvat, G., & Kimchi, T. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2013.274 · Cited by 204
Aripiprazole for autism spectrum disorders (ASD)
Hirsch, L. E., & Pringsheim, T. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009043.pub3 · Cited by 200
Genotype to phenotype relationships in autism spectrum disorders
Chang, J., Gilman, S. R., Chiang, A. H., Sanders, S. J., & Vitkup, D. (2015) · Nature Neuroscience · doi:10.1038/nn.3907 · Cited by 197 · cited 1×
“Moreover, genetic studies revealed that alteration in the developmental pathways of neuronal and axonal structures that are strongly involved in synaptogenesis emerge from single gene mutations (Geschwind, 2011; Voineagu et al., 2011; Chang et al., 2015).”
BackgroundKING, B. H., WRIGHT, D. M., HANDEN, B. L., SIKICH, L., ZIMMERMAN, A. W., MCMAHON, W., CANTWELL, E., DAVANZO, P. A., DOURISH, C. T., DYKENS, E. M., et al. (2001) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200106000-00010 · Cited by 196
Arnold, H. M., Burk, J. A., Hodgson, E. M., Sarter, M., & Bruno, J. P. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00292-0 · Cited by 195
Development of a mouse test for repetitive, restricted behaviors: Relevance to autism
Moy, S. S., Nadler, J. J., Poe, M. D., Nonneman, R. J., Young, N. B., Koller, B. H., Crawley, J. N., Duncan, G. E., & Bodfish, J. W. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.10.029 · Cited by 195 · cited 1×
“…(BALB), BTBR T+Itpr3tf/J (BTBR), C58/J (C58), and 129S1/SvImJ mice showed lack of sociability, as compared to inbred mouse strains with high sociability, such as C57BL/6J (B6) and FVB/NJ mice (Brodkin, 2007; Moy et al., 2007, 2008; McFarlane et al., 2008; Kazdoba et al., 2016; Hu et al., 2017).”
BackgroundDopamine D2 Receptors as Treatment Targets in Schizophrenia
Seeman, P. (2010) · Clinical Schizophrenia & Related Psychoses · doi:10.3371/csrp.4.1.5 · Cited by 193
Use of clonidine in children with autism spectrum disorders
Ming, X., Gordon, E., Kang, N., & Wagner, G. C. (2008) · Brain and Development · doi:10.1016/j.braindev.2007.12.007 · Cited by 183 · cited 4×
“Also, previous clinical trials carried out with clonidine in ASD subjects delivered evidences for the clinical effectiveness and safety profile in ASD and related brain disorders (Fankhauser et al., 1992; Ming et al., 2008).”
BackgroundResultInfluentialSamaco, R. C., McGraw, C. M., Ward, C. S., Sun, Y., Neul, J. L., & Zoghbi, H. Y. (2013) · Human Molecular Genetics · doi:10.1093/hmg/dds406 · Cited by 183
Uvebrant, P., & Bauzienè, R. (1994) · Neuropediatrics · doi:10.1055/s-2008-1073041 · Cited by 175
Clinical and Molecular Analysis of Five(Inv) Dup(15) Patients
Robinson, W. P., Binkert, F., Giné, R., Vazquez, C., Müller, W., Rosenkranz, W., & Schinzel, A. (1993) · European Journal of Human Genetics · doi:10.1159/000472386 · Cited by 173
MicroRNAs as biomarkers for CNS disease
Rao, P., Benito, E., & Fischer, A. (2013) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2013.00039 · Cited by 171
Epilepsy and epileptiform EEG: Association with autism and language disorders
Ballaban-Gil, K., & Tuchman, R. (2000) · Mental Retardation and Developmental Disabilities Research Reviews · doi:10.1002/1098-2779(2000)6:4<300::aid-mrdd9>3.0.co;2-r · Cited by 170
Executive and social behaviors under nicotinic receptor regulation
Granon, S., Faure, P., & Changeux, J.-P. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1533498100 · Cited by 170
Translational Mouse Models of Autism: Advancing Toward Pharmacological Therapeutics
Kazdoba, T. M., Leach, P. T., Yang, M., Silverman, J. L., Solomon, M., & Crawley, J. N. (2015) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2015_5003 · Cited by 170
Mikhail, F. M., Lose, E. J., Robin, N. H., Descartes, M. D., Rutledge, K. D., Rutledge, S. L., Korf, B. R., & Carroll, A. J. (2011) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.34177 · Cited by 168
16p13.11 duplication is a risk factor for a wide spectrum of neuropsychiatric disorders
Ramalingam, A., Zhou, X.-G., Fiedler, S. D., Brawner, S. J., Joyce, J. M., Liu, H.-Y., & Yu, S. (2011) · Journal of Human Genetics · doi:10.1038/jhg.2011.42 · Cited by 166
Histamine H3 receptor as a potential target for cognitive symptoms in neuropsychiatric diseases
Sadek, B. S., Saad, A. K., Sadeq, A. S., Jalal, F. Y., & Stark, H. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.06.051 · Cited by 162
Self-citationDivalproex sodium vs. placebo in the treatment of repetitive behaviours in autism spectrum disorder
Hollander, E., Soorya, L., Wasserman, S., Esposito, K., Chaplin, W., & Anagnostou, E. (2005) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145705005791 · Cited by 159
Epigenetic Regulation of UBE3A and Roles in Human Neurodevelopmental Disorders
LaSalle, J. M., Reiter, L. T., & Chamberlain, S. J. (2015) · Epigenomics · doi:10.2217/epi.15.70 · Cited by 156
Kron, M., Howell, C. J., Adams, I. T., Ransbottom, M., Christian, D., Ogier, M., & Katz, D. M. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.2159-12.2012 · Cited by 154 · cited 1×
“Amir et al., 1999; Chao et al., 2010; Katz et al., 2012; Kron et al., 2012; Samaco et al., 2013 Shank3B mutant mice Shank3A mutant mice Shank3(e4-9) mutant Phelan-McDermid syndrome SHANK3 (22q13) Restricted interest but no repetitive behavior, social interactions, learning, sensory, cognitive and…”
BackgroundWitkin, J. M., & Nelson, D. L. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.05.001 · Cited by 152
Balasubramaniyan, V., Boddeke, E., Bakels, R., Küst, B., Kooistra, S. M., Veneman, A., & Copray, S. C. V. M. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.08.082 · Cited by 149
The autism‐epilepsy connection
Levisohn, P. M. (2007) · Epilepsia · doi:10.1111/j.1528-1167.2007.01399.x · Cited by 146
Falluel‐Morel, A., Sokolowski, K., Sisti, H. M., Zhou, X., Shors, T. J., & DiCicco-Bloom, E. M. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04882.x · Cited by 145
Gray and White Matter Brain Chemistry in Young Children With Autism
Friedman, S. D., Shaw, D., Artru, A. A., Dawson, G., Petropoulos, H., & Dager, S. R. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.7.786 · Cited by 145
Sertraline in Adults With Pervasive Developmental Disorders: A Prospective Open-Label Investigation
McDougle, C. J., Brodkin, E. S., NAYLOR, S. T., Carlson, D. C., Cohen, D. J., & Price, L. H. (1998) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199802000-00010 · Cited by 145
Jahromi, L. B., Kasari, C. L., McCracken, J. T., Lee, L. S.-Y., Aman, M. G., McDougle, C. J., Scahill, L., Tierney, E., Eugene Arnold, L., Vitiello, B., et al. (2009) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-008-0636-9 · Cited by 144
Naaijen, J., Bralten, J., Poelmans, G., The IMAGE consortium, Faraone, S., Asherson, P., Banaschewski, T., Buitelaar, J., Franke, B., P Ebstein, R., et al. (2017) · Translational Psychiatry · doi:10.1038/tp.2016.273 · Cited by 142
Criteria for Validating Mouse Models of Psychiatric Diseases
Chadman, K., Yang, M., & Crawley, J. (2009) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30777 · Cited by 140
Takuma, K., Hara, Y., Kataoka, S., Kawanai, T., Maeda, Y., Watanabe, R., Takano, E., Hayata‐Takano, A., Hashimoto, H., Ago, Y., et al. (2014) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2014.08.013 · Cited by 138
What We Have Learned about Autism Spectrum Disorder from Valproic Acid
Chomiak, T., Turner, N. R., & Hu, B. (2013) · Pathology Research International · doi:10.1155/2013/712758 · Cited by 138
Nutritional and Dietary Interventions for Autism Spectrum Disorder: A Systematic Review
Sathe, N., Andrews, J. C., McPheeters, M. L., & Warren, Z. E. (2017) · PEDIATRICS · doi:10.1542/peds.2017-0346 · Cited by 138
Wang, H., Liu, J., Zong, Y., Xu, Y., Deng, W., Zhu, H., Liu, Y. M., Ma, C., Huang, L. J., Zhang, L., et al. (2010) · Brain Research · doi:10.1016/j.brainres.2010.08.023 · Cited by 137
Molecular genetics and animal models in autistic disorder
Andres, C. R. (2002) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00642-6 · Cited by 135
Baronio, D., Castro, K., Gonchoroski, T., de Melo, G. M., Nunes, G. D., Bambini-Júnior, V., Gottfried, C., & Riesgo, R. D. S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0116363 · Cited by 133
Altered expression of histamine signaling genes in autism spectrum disorder
Wright, C., Shin, J. H., Rajpurohit, A., Deep‐Soboslay, A., Collado‐Torres, L., Brandon, N. J., Hyde, T. M., Kleinman, J. E., Jaffe, A. E., Cross, A. J., et al. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.87 · Cited by 133
Mefford, H. C., Cooper, G. M., Zerr, T., Smith, J. D., Baker, C., Shafer, N., Thorland, E. C., Skinner, C., Schwartz, C. E., Nickerson, D. A., et al. (2009) · Genome Research · doi:10.1101/gr.094987.109 · Cited by 132
Hardan, A. Y., & Handen, B. L. (2002) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/104454602760386923 · Cited by 131
Reduced transcript expression of genes affected by inherited and de novo CNVs in autism
STAART Psychopharmacology Network, Nord, A. S., Roeb, W., Dickel, D. E., Walsh, T., Kusenda, M., O’Connor, K. L., Malhotra, D., McCarthy, S., Stray, S. M., et al. (2011) · European Journal of Human Genetics · doi:10.1038/ejhg.2011.24 · Cited by 129
Owley, T. B., Salt, J., Guter, S. J., Grieve, A. J., Walton, L., Ayuyao, N., LEVENTHAL, B. L., & Cook, E. H. (2006) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2006.16.517 · Cited by 127
Posey, D. J., Puntney, J. I., Sasher, T. M., Kem, D. L., & McDougle, C. J. (2004) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/1044546041649084 · Cited by 127 · cited 3×
“…revealed that the use of guanfacine, a selective α2 adrenergic receptor agonist used in the treatment of ADHD, anxiety, and hypertension, was accompanied with enhancements in insomnia, attention deficiency, hyperactivity, and tics (Posey et al., 2004; Scahill et al., 2006; Boellner et al., 2007).”
BackgroundHistamine Pharmacology and New CNS Drug Targets
Tiligada, E., Kyriakidis, K. D., Chazot, P. L., & Passani, M. B. (2010) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00212.x · Cited by 126
Bowton, E., Saunders, C., Reddy, I. A., Campbell, N. G., Hamilton, P. J., Henry, L. K., Coon, H. H., Sakrikar, D. S., Veenstra-VanderWeele, J. M., Blakely, R., et al. (2014) · Translational Psychiatry · doi:10.1038/tp.2014.90 · Cited by 126
Expanding the clinical spectrum associated with defects in CNTNAP2 and NRXN1
Gregor, A., Albrecht, B., Bader, I., Bijlsma, E. K., Ekici, A. B., Engels, H., Hackmann, K., Horn, D., Hoyer, J., Klapecki, J., et al. (2011) · BMC Medical Genetics · doi:10.1186/1471-2350-12-106 · Cited by 121 · cited 1×
“For example, deletions in gene encoding a protein contactin-associated protein 2 (CNTNAP2) has been linked to ASD (Stephan, 2008; Gregor et al., 2011; Nord et al., 2011).”
BackgroundLevetiracetam in Autistic Children: An Open-Label Study
Rugino, T. A., & SAMSOCK, T. C. (2002) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/00004703-200208000-00006 · Cited by 119
Interventions Targeting Sensory Challenges in Autism Spectrum Disorder: A Systematic Review
Weitlauf, A. S., Sathe, N. A., McPheeters, M. L., & Warren, Z. E. (2017) · PEDIATRICS · doi:10.1542/peds.2017-0347 · Cited by 119
Naltrexone in Young Autistic Children: A Double-Blind, Placebo-Controlled Crossover Study
Kolmen, B. K., Feldman, H. M., Handen, B. L., & Janosky, J. E. (1995) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199502000-00018 · Cited by 117
AProspective Open Trial of Guanfacine in Children with Pervasive Developmental Disorders
Scahill, L., Aman, M. G., McDougle, C. J., McCracken, J. T., Tierney, E., Dziura, J., Arnold, L. E., Posey, D., Young, C., Shah, B., et al. (2006) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2006.16.589 · Cited by 117
Davidson, P. W., Cory‐Slechta, D. A., Thurston, S. W., Huang, L., Shamlaye, C. F., Gunzler, D. D., Watson, G. E., van Wijngaarden, E., Zaręba, G., Klein, J. D., et al. (2011) · NeuroToxicology · doi:10.1016/j.neuro.2011.08.003 · Cited by 116
Prefrontal nicotinic receptors control novel social interaction between mice
Avale, M. E., Chabout, J., Pons, S., Serreau, P., De Chaumont, F., Olivo‐Marin, J., Bourgeois, J., Maskos, U., Changeux, J., & Granon, S. (2011) · The FASEB Journal · doi:10.1096/fj.10-178558 · Cited by 114
Genetic evidence for role of integration of fast and slow neurotransmission in schizophrenia
Devor, A., Andreassen, O. A., Wang, Y., Mäki‐Marttunen, T., Smeland, O. B., Fan, C.-C., Schork, A. J., Holland, D., Thompson, W. K., Witoelar, A., et al. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.33 · Cited by 114
Bouvard, M. P., Leboyer, M., Launay, J.-M., Recasens, C., Plumet, M.-H., Waller-Perotte, D., Tabuteau, F., Bondoux, D., Dugas, M., Lensing, P., et al. (1995) · Psychiatry Research · doi:10.1016/0165-1781(95)02601-r · Cited by 112
Nondisjunction of chromosome 15: origin and recombination
Robinson, W. P., Bernasconi, F., Mutirangura, A., Ledbetter, D. H., Langlois, S., Malcolm, S., Morris, M. A., & Schinzel, A. (1993) · PubMed · doi:10.5167/uzh-233049 · Cited by 111
Martin, A., Koenig, K. M., Anderson, G. M., & Scahill, L. D. (2003) · Journal of Autism and Developmental Disorders · doi:10.1023/a:1022234605695 · Cited by 110
Fluoxetine in Treatment of Adolescent Patients with Autism: A Longitudinal Open Trial
Fatemi, S. H., Realmuto, G. M., Khan, L., & THURAS, P. D. (1998) · Journal of Autism and Developmental Disorders · doi:10.1023/a:1026008602540 · Cited by 110
A Pilot Study of Clomipramine in Young Autistic Children
SANCHEZ, L. E., Campbell, M., Small, A. M., Cueva, J. E., Armenteros, J. L., & Adams, P. (1996) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199604000-00021 · Cited by 110
Sertraline response in adults with mental retardation and autistic disorder.
Hellings, J. A., Kelley, L. A., Gabrielli, W. F., Kilgore, E., & Shah, P. (1996) · PubMed · Cited by 109
Drug therapy in autism: a present and future perspective
Kumar, B., Prakash, A., Sewal, R. K., Medhi, B., & Modi, M. (2012) · Pharmacological Reports · doi:10.1016/s1734-1140(12)70927-1 · Cited by 109
Stubbs, G., Henley, K., & Green, J. (2016) · Medical Hypotheses · doi:10.1016/j.mehy.2016.01.015 · Cited by 107
Genetic and non-genetic animal models for autism spectrum disorders (ASD)
Ergaz, Z., Weinstein-Fudim, L., & Ornoy, A. (2016) · Reproductive Toxicology · doi:10.1016/j.reprotox.2016.04.024 · Cited by 107
DeLong, G. R., Ritch, C. R., & Burch, S. (2002) · Developmental Medicine & Child Neurology · doi:10.1017/s0012162201002717 · Cited by 106
Clinical effects of clozapine on autistic disorder
Zuddas, A., Ledda, M. G., Fratta, A. L., Muglia, P., & Cianchetti, C. (1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.5.738a · Cited by 105
Decoding the contribution of dopaminergic genes and pathways to autism spectrum disorder (ASD)
Nguyen, M., Roth, A., Kyzar, E. J., Poudel, M. K., Wong, K., Stewart, A., & Kalueff, A. V. (2014) · Neurochemistry International · doi:10.1016/j.neuint.2014.01.002 · Cited by 104
Quetiapine in Nine Youths with Autistic Disorder
Findling, R. L., McNamara, N., Gracious, B., O’Riordan, M. A., Reed, M. D., Demeter, C., & Blumer, J. L. (2004) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/1044546041649129 · Cited by 103
Detection of Circulating miRNA Levels in Schizophrenia
Wei, H., Yuan, Y., Liu, S., Wang, C., Yang, F., Lu, Z. F., Wang, C., Deng, H., Zhao, J., Shen, Y., et al. (2015) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.14030273 · Cited by 103
Issues in the Management of Challenging Behaviours of Adults with Autism Spectrum Disorder
Matson, J. L., Sipes, M., Fodstad, J. C., & Fitzgerald, M. E. (2011) · CNS Drugs · doi:10.2165/11591700-000000000-00000 · Cited by 102
An Open-Label Trial of Escitalopram in Pervasive Developmental Disorders
Owley, T. B., Walton, L., Salt, J., Guter, S. J., Winnega, M., LEVENTHAL, B. L., & Cook, E. H. (2005) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000153229.80215.a0 · Cited by 100
Mcconville, B. J., Sanberg, P. R., Fogelson, M. H., King, J., Cirino, P. T., Parker, K. W., & Norman, A. B. (1992) · Biological Psychiatry · doi:10.1016/0006-3223(92)90315-q · Cited by 99
AProspective, Open-Label Trial of Galantamine in Autistic Disorder
Nicolson, R., Craven‐Thuss, B., & Smith, J. (2006) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2006.16.621 · Cited by 98
Hettinger, J. A., Liu, X., Schwartz, C. E., Michaelis, R. C., & Holden, J. J. A. (2008) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30655 · Cited by 95
Excessive D1 Dopamine Receptor Activation in the Dorsal Striatum Promotes Autistic-Like Behaviors
Lee, Y., Kim, H., Kim, J., Park, J. Y., Choi, J., Lee, J. E., Lee, E. H., & Han, P. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0770-5 · Cited by 94
Secular changes in the symptom level of clinically diagnosed autism
Arvidsson, O., Gillberg, C., Lichtenstein, P., & Lundström, S. (2018) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12864 · Cited by 91
Autism Spectrum Disorders: Translating human deficits into mouse behavior
Pasciuto, E., Borrie, S. C., Kanellopoulos, A. K., Santos, A. R., Cappuyns, E., D’Andrea, L., Pacini, L., & Bagni, C. (2015) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2015.07.013 · Cited by 91
Grozeva, D., Conrad, D. F., Barnes, C. P., Hurles, M. E., Owen, M. J., O’Donovan, M. C., Craddock, N. J., & Kirov, G. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.11.004 · Cited by 89
Serotonin rebalances cortical tuning and behavior linked to autism symptoms in 15q11-13 CNV mice
Nakai, N., Nagano, M., Saitow, F., Watanabe, Y., Kawamura, Y., Kawamoto, A., Tamada, K., Mizuma, H., Onoe, H., Watanabe, Y., et al. (2017) · Science Advances · doi:10.1126/sciadv.1603001 · Cited by 89
Hsieh, G. C., Chandran, P., Salyers, A. K., Pai, M., Zhu, C., Wensink, E. J., Witte, D. G., Miller, T. R., Mikusa, J. P., Baker, S. J., et al. (2009) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2009.12.004 · Cited by 87
Shan, L., Bossers, K., Luchetti, S., Balesar, R. A., Lethbridge, N. L., Chazot, P. L., Bao, A., & Swaab, D. F. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.10.016 · Cited by 87
Clozapine in the Treatment of Aggression in an Adolescent With Autistic Disorder
Chen, N. C., Bedair, H. S., McKay, B. G., Bowers, M. B., & Mazure, C. M. (2001) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v62n0612h · Cited by 87
Management of hyperactivity and other acting-out problems in patients with autism spectrum disorder
Aman, M. G. (2004) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2004.07.006 · Cited by 86
Monogenic mouse models of autism spectrum disorders: Common mechanisms and missing links
Hulbert, S. W., & Jiang, Y. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.12.040 · Cited by 86
McCool, M. F., Patel, S. J., Talati, R., & Ragozzino, M. E. (2007) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2007.06.005 · Cited by 85
Di Martino, A., Melis, G., Cianchetti, C., & Zuddas, A. (2004) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/1044546041649011 · Cited by 82 · cited 2×
“…the most commonly known CNS stimulant widely used in the therapeutic management of attention deficit hyperactivity disorder (ADHD) and narcolepsy, is commonly indicated for ASD children and adolescents (Handen et al., 2000; Di Martino et al., 2004; Jahromi et al., 2009; Kim et al., 2017).”
BackgroundWang, L., Almeida, L. E. F., Spornick, N., Kenyon, N. J., Kamimura, S., Khaibullina, A., Nouraie, M. S., & Quezado, Z. (2015) · Psychopharmacology · doi:10.1007/s00213-015-4058-z · Cited by 78
The Neglected Role of Histamine in Alzheimer’s Disease
Naddafi, F., & Mirshafiey, A. (2013) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317513488925 · Cited by 77
Paroxetine Treatment of Aggression and Self-Injury in Persons With Mental Retardation
Davanzo, P. A., Belin, T. R., Widawski, M. H., & King, B. H. (1997) · American Journal on Mental Retardation · doi:10.1352/0895-8017(1998)102<0427:ptoaas>2.0.co;2 · Cited by 77
Pediatrics Efficacy and Safety of Naltrexone Use in Pediatric Patients with Autistic Disorder
Ei-Chaar, G. M., Maisch, N. M., Augusto, L. G., & Wehring, H. J. (2006) · Annals of Pharmacotherapy · doi:10.1345/aph.1g499 · Cited by 76
Tabet, A., Verloès, A., Pilorge, M., Delaby, E., Delorme, R., Nygren, G., Devillard, F., Gérard, M., Passemard, S., Héron, D., et al. (2015) · Molecular Autism · doi:10.1186/s13229-015-0015-2 · Cited by 75
Pre- and Perinatal Risk Factors for Autism Spectrum Disorder in a New Jersey Cohort
Maramara, L. A., He, W., & Ming, X. (2014) · Journal of Child Neurology · doi:10.1177/0883073813512899 · Cited by 73
Cherry-picked ligands at histamine receptor subtypes
Sadek, B. S., & Stark, H. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.11.005 · Cited by 72
Self-citationBehavioral and Cerebellar Transmission Deficits in Mice Lacking the Autism-Linked Gene Islet Brain-2
Giza, J., Urbanski, M. J., Prestori, F., Bandyopadhyay, B., Yam, A., Friedrich, V., Kelley, K., D'Angelo, E., & Goldfarb, M. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.1161-10.2010 · Cited by 68 · cited 2×
“…and increased fear conditioning (Ergaz et al., 2016), Phelan-McDermid syndrome with restricted interest as well as cognitive and motor deficits (Giza et al., 2010; Ergaz et al., 2016), PTEN mutations, cortical dysplasia focal epilepsy with deficits in regard to social interactions, restricted…”
BackgroundBrowman, K. E., Komater, V. A., Curzon, P., Rueter, L. E., Hancock, A. A., Decker, M. W., & Fox, G. B. (2003) · Behavioural Brain Research · doi:10.1016/j.bbr.2003.11.001 · Cited by 68
Emerging Pharmacotherapies for Neurodevelopmental Disorders
Wetmore, D. Z., & Garner, C. C. (2010) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/dbp.0b013e3181ee3833 · Cited by 63
FXR1P But Not FMRP Regulates the Levels of Mammalian Brain-Specific microRNA-9 and microRNA-124
Xu, X., Zong, R.-T., Li, Z., Biswas, M. H. U., Fang, Z. M., Nelson, D. L., & Gao, F. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.2827-11.2011 · Cited by 63
Autism risk following antidepressant medication during pregnancy
Viktorin, A., Uher, R., Reichenberg, A., Levine, S. Z., & Sandin, S. (2017) · Psychological Medicine · doi:10.1017/s0033291717001301 · Cited by 62
Patterson, P. H. (2011) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2011.09.008 · Cited by 62
Analysis of CHRNA7 rare variants in autism spectrum disorder susceptibility
Bacchelli, E., Battaglia, A., Cameli, C., Lomartire, S., Tancredi, R., Thomson, S. A. M., Sutcliffe, J. S., & Maestrini, E. (2015) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.36847 · Cited by 61
Psychological Approaches to Chronic Catatonia-like Deterioration in Autism Spectrum Disorders
Shah, A., & Wing, L. (2006) · International review of neurobiology · doi:10.1016/s0074-7742(05)72015-8 · Cited by 60
Imipramine in preschool autistic and schizophrenic children
Campbell, M., Fish, B., Shapiro, T., & Floyd, A. (1971) · Journal of Autism and Developmental Disorders · doi:10.1007/bf01557348 · Cited by 60
Hara, Y., Ago, Y., Taruta, A., Hasebe, S., Kawase, H., Tanabe, W., Tsukada, S., Nakazawa, T., Hashimoto, H., Matsuda, T., et al. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4703-9 · Cited by 60
Potential utility of histamine H3 receptor antagonist pharmacophore in antipsychotics
von Coburg, Y., Kottke, T., Weizel, L., Ligneau, X., & Stark, H. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.09.012 · Cited by 59
Chen, R., Davis, L. K., Guter, S. J., Wei, Q., Jacob, S., Potter, M. H., Cox, N. J., Cook, E. H., Sutcliffe, J. S., & Li, B. (2017) · Molecular Autism · doi:10.1186/s13229-017-0130-3 · Cited by 59
Cited by
Chen, Y., Xu, J., & Chen, Y. (2021) · Nutrients · doi:10.3390/nu13062099 · Cited by 917
Clinical practice guidelines for autism spectrum disorders
Subramanyam, A., Mukherjee, A., Dave, M., & Chavda, K. (2019) · Indian Journal of Psychiatry · doi:10.4103/psychiatry.indianjpsychiatry_542_18 · Cited by 59
Arakawa, H. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.592408 · Cited by 32
Serotonergic neuromodulation of synaptic plasticity
Higa, G. S. V., Viana, F. J. C., Francis-Oliveira, J., Cruvinel, E., Franchin, T. S., Marcourakis, T., Ulrich, H., & De Pasquale, R. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.110036 · Cited by 29
Metadata
- Authors
- Eissa, N., Al-Houqani, M., Sadeq, A., Ojha, S. K., Sasse, A., & Sadek, B.
- Venue
- Frontiers in Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2018-05-16
- Volume
- 12
- Pages
- 304-304
- ISSN
- 1662-453X (ISSN-L)
- OpenAlex
- W2803899179
- Cited by
- 260
- References
- 245
- FWCI
- 10.79
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.